PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence

07 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum

02 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results

28 фев 2023 16:03:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston

13 фев 2023 16:02:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue  

09 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference

14 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

03 ноя 2022 16:03:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022

12 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces $52 Million Debt Refinancing

10 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

Providence Advances Surgical Robotics Program with Multi-System, National Contract for PROCEPT BioRobotics AquaBeam Systems

19 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference

22 авг 2022 16:03:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

04 авг 2022 16:03:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022

14 июл 2022 16:02:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates

09 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

05 май 2022 16:02:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy for Men with Enlarged Prostates

28 апр 2022 08:00:03 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on May 11, 2022

12 апр 2022 16:02:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces Investor Event at 2022 AUA Annual Meeting in New Orleans

11 апр 2022 08:00:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results

08 мар 2022 07:00:00 Источник Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

22 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire